Description:
WOLFRAM SYNDROME
WOLFRAMIN ER TRANSMEMBRANE GLYCOPROTEIN; WFS1
Repository
|
NIGMS Human Genetic Cell Repository
|
Subcollection |
Heritable Diseases |
Class |
Other Disorders of Known Biochemistry |
Cell Type
|
Fibroblast
|
Transformant
|
Untransformed
|
Race
|
White
|
Family Member
|
1
|
Relation to Proband
|
proband
|
Confirmation
|
Clinical summary/Case history
|
Species
|
Homo sapiens
|
Common Name
|
Human
|
Remarks
|
|
Passage Frozen |
3 |
|
IDENTIFICATION OF SPECIES OF ORIGIN |
Species of Origin Confirmed by Nucleoside Phosphorylase Isoenzyme Electrophoresis |
|
Gene |
WFS1 |
Chromosomal Location |
4p16.1 |
Allelic Variant 1 |
606201.0005; WOLFRAM SYNDROME 1; WFS1 |
Identified Mutation |
c.1944G>A (p.W648X) |
|
Gene |
WFS1 |
Chromosomal Location |
4p16.1 |
Allelic Variant 2 |
606201.0004; WOLFRAM SYNDROME 1 |
Identified Mutation |
c.2084G>T (p.G695V) |
Remarks |
Onset at age 11; optic atrophy; on Insulin; 2 affected sibs; see GM01795A Lymphoid |
Grzela DP, Marciniak B, Pulaski L, Characterization of an induced pluripotent stem cell line (IMBPASi001-A) derived from fibroblasts of a patient affected by Wolfram Syndrome Stem cell research46:101858 2020 |
PubMed ID: 32521500 |
|
Buck D, Greene AE, Coriell LL, Mulivor RA, Juvenile onset diabetes. Cytogenet Cell Genet28:213-6 1980 |
PubMed ID: 7438795 |
Passage Frozen |
3 |
Split Ratio |
1:3 |
Temperature |
37 C |
Percent CO2 |
5% |
Medium |
Eagle's Minimum Essential Medium with Earle's salts and non-essential amino acids with 2mM L-glutamine or equivalent |
Serum |
15% fetal bovine serum Not inactivated |
Substrate |
None specified |
Subcultivation Method |
trypsin-EDTA |
Supplement |
- |
|
|